ZURA (zurabio.com) Sof foyda

ZURA (Zura Bio) - kompaniyaning tovar belgisi

Ushbu narxlar grafigi Zura Bio Limited (ZURA) kompaniyasining narxlar dinamikasini aks ettiradi, uning foydasi -0.12 miqdorini tashkil etadi. Biznes immun terapiyalarining bozorga kirishini tezlashtirish uchun biolaboratoriyalar bilan ittifoqlar tuzishga tayanadi. Biroq, savdolarning yo'qligi va II bosqich sinovlarida muvaffaqiyatsizlik ehtimoli xatarlarni yuzaga keltirmoqda. Yuqori R&D xarajatlari yangi aksiyalar chiqarilishiga va aksiyadorlar kapitalining qadrsizlanishiga olib kelishi mumkin.

ZURA (Zura Bio) Sof foyda tarixi 28.04.2023dan 31.10.2026gacha

Zura Bio (ZURA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari zurabio.com|ZURA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Zura Bio|ZURA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Zura Bio|ZURA - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi zurabio.com|ZURA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Zura Bio Limited|ZURA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Zura Bio Ltd|ZURA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Zura Bio|ZURA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Zura Bio|Shoshilinch likvidlik zurabio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ZURA - Sof daromad
Kompaniyaning jamlanma tahlili:Zura Bio Limited
Zura Bio Limited asosiy tovari

Investitsiya risklarini minimallashtirish uchun Zura Bio Limited (ZURA) operatsion samaradorlikni monitoring qilishni talab qiladi. Ushbu metrika treyderlarning bozor konsensusini umumlashtirib, emitentning haqiqiy kunlik moliyaviy natijasini aks ettiradi. Kompaniyaning sof foydasini tahlil qilish yashirin xavflarni yoki aktivning o'sish potentsialini aniqlash imkonini beradi. Ushbu ko'rsatkichning barqarorligi xomashyo oqimini diversifikatsiya qilish samaradorligini tasdiqlaydi. Klinik dori vositalarining uzluksiz logistikasi bevosita foydaning barqarorligiga aylanadi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN: Sof daromad|Soliqdan keyingi foyda PHAR|NKTR (Nektar Therapeutics) - Sof daromad|upstreambio.com (UPB) - Sof foyda|Kompaniyaning sof foydasi Zenas Biopharma|IMNM: Yakuniy foyda|Sof foyda GOSS|Sof foyda KalVista Corp (KALV)|Septerna Inc - Sof daromad|Yakuniy foyda PVLA|Savara - Sof foyda|RIGL: Kompaniyaning sof foydasi|ANAB: Sof foyda|ATXS - Sof moliyaviy natija|Kompaniyaning sof foydasi enGene Holdings Inc.|Kompaniyaning sof daromadi rapt.com RAPT|Sof daromad JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris Therapeutics Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi Kyverna KYTX|Tiziana Life Sciences, Ltd. - Kompaniyaning sof foydasi|Cabaletta Bio, Inc. - Sof foyda|Sof moliyaviy natija ventyxbio.com VTYX|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Sof daromad Avalo Therapeutics, Inc.|ELDN (Eledon) - Sof foyda|Agenus, Inc (AGEN) - Sof moliyaviy natija|Sof daromad CLYM (Climb Bio Inc)|Soliqlar to‘langandan keyingi foyda ATYR|Sof foyda ADAG (Adagene Inc.)|ImageneBio (IMA) - Kompaniyaning sof daromadi|Shattuck Therapeutics - Sof foyda|EQ (Equillium, Inc.) - Kompaniya foydasi|CNTB (connectbiopharm.com) - Sof daromad|Soliqdan keyingi foyda IMUX (Immunic)|Sof daromad ATRA|Sof foyda InflaRx GmbH|Kompaniyaning sof foydasi X4 Pharma (XFOR)|ACET (adicetbio.com) - Yakuniy foyda|Sof foyda CELU (Celularity)|Sof foyda inmunebio.com INMB|BRNS - Kompaniyaning sof foydasi|Soliqdan keyingi foyda KZR|SABS: Sof foyda|Akari Therapeutics, Plc - Yakuniy foyda|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Sof foyda Q32 Bio Corp|Kompaniyaning sof foydasi GeoVax (GOVX)|EDSA (Edesa Biotech Inc) - Yakuniy foyda|Kompaniyaning sof foydasi iBio Corp IBIO|CARM - Sof daromad|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|HCWB (hcwbiologics.com) - Sof daromad|Aptevo Therapeutics Inc. - Yakuniy foyda|AIM (AIM ImmunoTech) - Sof foyda|Aditxt Corp (ADTX) - Sof moliyaviy natija|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB - Sof daromad|INDP: Sof daromad|SCNI - Sof foyda|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Kompaniya foydasi AFMD|ALLK (Allakos Inc) - Sof foyda|Kompaniyaning sof daromadi HOOKIPA HOOK|Sof daromad IGMS (IGM Biosciences, Inc.)|ITOS: Soliqdan keyingi foyda|Ocean Biomedical, Inc. - Sof daromad|Sof foyda tcbiopharm.com TCBP|THRD - Kompaniyaning sof foydasi